Sunday, 21. of December 2014
Select your Country
worldheart
We comply with the HONcode standard for trustworthy health
information:
verify here.

ISMAAP seven years on

Seven years ago representative of five countries founded the International Self-Monitoring Association of oral Anticoagulated Patients (ISMAAP) 2002 in Geneva, Switzerland. The target is up today: "To motivate patients to take control of their own oral anticoagulation".

Due to big efforts and lots of activities during the last years INR self-monitoring became more popular. And these efforts bear fruits: In some countries and regions of countries the reimbursement for the test strips and the devices have been granted by the health insurances.

Meanwhile representaive of ten European countries are member of ISMAAP.

C.Schaefer, July 2009

The International Self-Monitoring Association of oral Anticoagulated Patients (ISMAAP)

was first proposed in Paris, France, in July 2001. It was officially founded in Geneva, Switzerland, in July 2002 on the initiative of representatives of National Associations of patients on oral anticoagulation therapy.
In some countries, doctors generally or the thrombosis service agree that patients should manage the self-monitoring of long-term oral anticoagulation on their own and take control of their anticoagulation therapy. In these countries, reimbursement of the necessary equipment for self-monitoring is usually granted by the national health insurance authority.
However, in other countries, self-monitoring of long-term oral anticoagulation can be carried out only in very close cooperation with the general practitioner and/or the lab. In these countries, reimbursement by the national health insurance authority of the necessary equipment is for self-monitoring not yet possible.

The main activities of ISMAAP focus on patients on long-term oral anticoagulation, motivating them to take control of their own oral anticoagulation therapy and consequently achieve a better quality of therapy and an improved quality of life. Accordingly, the Association intends to issue patient guidelines that take into account the culture of international groups and the different status of patiens (age, educational level, family environment, etc.).

Objectives
ISMAAP aims to give patients continuous support about life on oral anticoagulation therapy and to motivate them to carry out self-monitoring to reduce the potential risks of thrombosis and haemorrhage.